270257-39-1

Basic information

• Product Name: (1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate
• Synonyms: (1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate;p-Toluenesulfonic acid (1-benzyl-4-cyano-4-piperidyl)methyl ester;(1-benzyl-4-cyanopiperidin-4-yl)Methyl 4-Methylbenzene-1-sulfonate
• CAS NO: 270257-39-1
• Molecular Formula: C₂₁H₂₄N₂O₃S
• Molecular Weight: 384.498
• Mol File: 270257-39-1.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 552.3°C at 760 mmHg
• Flash Point: 287.8°C
• Appearance: /
• Density: 1.26g/cm³
• Vapor Pressure: 3.03E-12mmHg at 25°C
• Refractive Index: 1.61
• Storage Temp.: 2-8°C
• PKA: 6.19±0.10(Predicted)
• CAS DataBase Reference: (1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: (1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate(270257-39-1)
• EPA Substance Registry System: (1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate(270257-39-1)

Safety Data

• Hazardous Substances Data: 270257-39-1(Hazardous Substances Data)

Usage

General Description

(1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate is a chemical compound with a complex structure consisting of a benzyl group, a cyanopiperidine ring, a methyl group, and a benzenesulfonate moiety. (1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate may have potential uses in medicinal chemistry and drug development due to its structural features and potential interactions with biological targets. However, its specific properties, uses, and potential applications would need to be further investigated through experimentation and research. Additionally, its potential toxicity, environmental impact, and safety considerations would also need to be thoroughly evaluated before any practical applications.

InChI:InChI=1/C21H24N2O3S/c1-18-7-9-20(10-8-18)27(24,25)26-17-21(16-22)11-13-23(14-12-21)15-19-5-3-2-4-6-19/h2-10H,11-15,17H2,1H3

Upstream product

• 162686-53-5 C₁₄H₁₈N₂O 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 135380-52-8 7-benzyl-2,7-diazaspiro[3.5]nonane 

Relevant articles and documents

NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES

The invention provides compounds of general formula (I) wherein A, B, p, w, x, y, and z are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.